- FDA approves Plan B One-Step OTC switch
- Senate passes Drug Quality and Security Act
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- FDA approves liquid form of enalapril to treat BP in children, adults
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
SILVER SPRING, Md. — The Food and Drug Administration on Friday warned U.S. consumers not to use the emergency birth control medicine labeled as Evital, as it may be a counterfeit version of the “morning after pill” and may not be safe or effective in preventing pregnancy.
In addition, no brand labeled Evital has been approved by the FDA for use in the United States.
The FDA is especially concerned that Evital may be in distribution in some Hispanic communities. The packaging label of the counterfeit version says, “Evital Anticonceptivo de emergencia, 1.5 mg, 1 tablet,” by “Fluter Domull."
For more information about counterfeit medicine, click here.